Month 1: Initiation Phase (6 to 12 Units Daily) The initiation phase establishes baseline tolerance
By inhibiting NNMT, 5-Amino-1MQ appears to improve how the body handles glucose
Mathew B, Amaechi C, Asante K, Albuquerque E, Benedict A, Kneeream E, Lopez L, et al
Combined with baseline and periodic lab monitoring, genetic insights help PlexusDx optimize nutrient support alongside tirzepatide therapy, maximizing weight loss efficacy and patient satisfaction
Its most important role is in the formation of nucleic acids (DNA) from amino acids
Pharmacological treatments are reserved for specific circumstances and limited to licensed medications with demonstrated efficacy and safety profiles, such as orlistat or semaglutide (NICE TA875)